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Abstract
Introduction: Prolonged fever occurs with infectious and noninfectious diseases but is poorly studied in intensive
care units. The aims of this prospective multicenter noninterventional study were to determine the incidence and
etiologies of prolonged fever in critically ill patients and to compare outcomes for prolonged fever and short-
lasting fever.
Methods: The study involved two periods of 2 months each, with 507 patients hospitalized ≥ 24 hours. Fever was
defined by at least one episode of temperature ≥ 38.3°C, and prolonged fever, as lasting > 5 days. Backward
stepwise logistic regression was performed to identify the independent factors associated with prolonged fever
versus short-lasting fever.
Results: Prolonged or short-lasting fever occurred in 87 (17%) and 278 (55%) patients, respectively. Infectious and
noninfectious causes were found in 54 (62%) and 27 (31%) of 87 patients, respectively; in six patients (7%),
prolonged fever remained unexplained. The two most common sites of infection were ventilator-associated
pneumonia (n = 25) and intraabdominal infection (n = 13). Noninfectious fever (n = 27) was neurogenic in 19
(70%) patients and mainly associated with cerebral injury (84%). Independent risk factors for prolonged fever were
cerebral injury at admission (OR = 5.03; 95% CI, 2.51 to 10.06), severe sepsis (OR = 2.79; 95% CI, 1.35 to 5.79),
number of infections (OR = 2.35; 95% CI, 1.43 to 3.86), and mechanical-ventilation duration (OR = 1.05; 95% CI, 1.01
to 1.09). Older patients were less likely to develop prolonged fever. ICU mortality did not differ between the two
groups.
Conclusions: Prolonged fever was common, mainly due to severe infections, particularly ventilator-associated
pneumonia, and mixed infectious causes were frequent, warranting systematic and careful search for multiple
causes. Neurogenic fever was also especially frequent.
Introduction
Fever is a frequent symptom in the intensive care unit
(ICU), with rates ranging from 28% to 70%; its frequency
depends of the types of patients evaluated, the threshold
of definition of fever, and the duration of evaluation
[1-4]. In a large, recent retrospective study involving
more than 20,000 types of intensive care patients in the
same hospital, fever ( ≥ 38.3°C) and high fever ( > 39.5°C)
were reported in 44% and 8%, respectively [2].
If evaluation of new-onset fever in intensive care adult
patients is well standardized [5], the problem caused by
prolonged fever ( > 5 days) has not been well studied,
although it has been recognized to occur in 8% to 18% of
patients and is related mainly to infectious etiologies
[1-3]. These findings urge us to define better the spec-
trum of prolonged fever in a wide population of critically
ill patients. Indeed, we hypothesized that prolonged fever
may have a high percentage of noninfectious causes and/
or particular etiologies that could modify the care of criti-
cally ill patients.
Accordingly, the objectives of this study were to deter-
mine the incidence and etiologies of prolonged fever, to
evaluate morbidity and mortality of fever, and to deter-
mine its risk factors compared with short-lasting fever in
patients in the ICU.
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Materials and methods
This prospective observational study was conducted in
three surgical ICUs in university hospitals in France
(Nantes, Poitiers, and Rennes), and included two periods
of 2 months each (May 1, 2010, to June 30, 2010, and
September 1, 2010, to October 31, 2010) to avoid possi-
ble temporal etiology variations. During the two periods
of study, a total of 596 patients were admitted in the
ICUs, and 507 patients hospitalized ≥ 24 hours in the
ICUs were analyzed (Figure 1). The local ethics commit-
tee waived informed consent because this was a nonin-
terventional study (Comité d’éthique du CHU de
Rennes, France, n°10.03).
At least every 6 hours (or more frequently if the clinical
conditions required), nurses measured the patients’ core
temperatures at the axilla by using a digital thermometer
according to the recommendations of the manufacturer
(Thermofina; Z.A.C. Chamlys, Dammarie-Les-Lys,
France). The temperature recorded was that provided
when the acoustic signal was heard and by adding 0.5°C.
When a pulmonary artery catheter was in place, the tem-
perature recorded was obtained through this device.
At admission, the following data were recorded: age,
gender, McCabe score, type of admission (medical,
scheduled or nonscheduled surgery, and trauma), and
presence of a cerebral injury, whatever the origin at
admission. Severity was assessed by the severity acute
physiology score II (SAPS II) and sequential organ failure
assessment (SOFA). The presence of an infection, bacter-
emia, and the infected sites were also recorded.
During the ICU hospitalization, the number of infected
patients, the mean number of infections per patient, the
infected sites, the occurrence of bacteremia, severe sepsis
or septic shock, antibiotic use and its duration, the dura-
tion of mechanical ventilation, and development of acute
respiratory distress syndrome (ARDS) or acute renal fail-
ure were noted. Maximum leukocyte counts and C-reac-
tive protein levels measured during the ICU stay were
recorded. Acetaminophen (grams per day) or extracorpor-
eal devices used (continuous renal replacement therapy or
extracorporeal membrane oxygenation), known to inter-
fere with the magnitude of the temperature, were reported.
The ICU and hospital lengths of stay and ICU mortality
were also recorded. The proportion of microorganisms
recovered at admission and during the ICU stay were
recorded and divided into those cultured from normally
sterile sites (blood, mediastinum, intraabdominal, and
others) and those cultured from potentially contaminated
sites (urine, endotracheal tube aspirate, and others).
The search for the etiology of prolonged fever was left to
the discretion of the physicians. Nevertheless, careful con-
sideration was deemed necessary for viral infection, venous
thrombosis, and evaluation of the possibility of medica-
tion-induced fever. Final diagnosis of infection was made,
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Figure 1 Trial profile.
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according to the definitions proposed by the International
Sepsis Forum Consensus Conference [6] at the end of the
ICU hospitalization by an experienced and independent
intensivist at each center.
Definitions
Fever was defined as at least one episode of temperature
≥ 38.3°C, and prolonged fever as that lasting at least 5
days, as previously reported [1-3,5]. Surgical patients
were those who had undergone surgery in the 4 weeks
preceding admission (elective surgery was a surgery
scheduled > 24 hours in advance, and emergency sur-
gery was that scheduled within 24 hours of operation).
Trauma admissions were defined as ICU admissions
directly related to, or occurring as a complication of, a
traumatic event in the 30 days preceding admission.
Neurogenic fever refers to unexplained fever in patients
who had a cerebral injury, whatever the cause, and was
retained after thorough investigations for infectious and
noninfectious causes. Unexplained fever in other types
of patients referred to patients without cerebral injury
and retained after thorough investigations for infectious
and non-infectious causes. Sepsis, severe sepsis, and sep-
tic shock were defined accordingly to the Bone criteria
[7], and ARDS, as persistent and bilateral opacities on
chest radiographs associated with a PaO2/FiO2 ratio <
200 without cardiac failure or left atrial hypertension
[8]. Acute renal failure was defined as a serum creati-
nine concentration > 4 mg/dl (350 μM), or an acute
increase in serum creatinine concentration (3 × baseline
value), or a urine output < 0.3 ml/kg during 12 hours or
anuria during 12 hours [9].
Statistical analysis
All statistical analyses were performed by using SAS 9.1
Statistical Software (SAS Institute, Cary, NC, USA).
Values are expressed as means (standard deviation) or
medians (interquartile range) and as numbers (%) as
required. Patients were separated into two independent
groups: prolonged fever and short-lasting fever. First,
categoric variables were compared by using the c2 or
Fisher Exact test. Continuous variables were compared
by using the Student t test. For building the model in
multivariate analysis, we selected variables with an
external clinical judgment among those with a P ≤ 0.20
in univariate analysis. Backward stepwise logistic regres-
sion was performed to identify the independent factors
associated with prolonged fever. The calibration of the
models was tested with a Hosmel-Lemeshow test. Boot-
strap procedure with repeated sampling was performed
to validate the model stability. Odds ratios (ORs) and
95% confidence intervals (95% CIs) were calculated. P <
0.05 was considered statistically significant.
Results
Prolonged fever was observed in 87 (17%) of 507
patients. Body temperature was measured in the pul-
monary artery catheter in 86 (17%) of 507 of our
patients, this catheter being inserted for a mean dura-
tion of 5.4 ± 1.5 days. Table 1 lists the baseline charac-
teristics of the patients.
Ninety-seven etiologies of prolonged fever were found
in 87 patients and detailed in Table 2. Infectious and
noninfectious causes were found in 54 (62%) and 27
(31%) of 87 patients, respectively, and prolonged fever
remained unexplained in six (7%) patients. In 14 (16%)
patients, prolonged fever was related to several causes;
the main association was infective in 10 of 14 patients,
and in four cases, the cause could not be distinguished
between an infectious or a noninfectious cause. More
than one cause of prolonged fever was significantly less
frequent in patients who had shorter durations of fever
(five of 278 versus 14 of 87; P < 0.001).
The two most common types of infection were venti-
lator-associated pneumonia (VAP) and intraabdominal
infection. VAP was associated with one (n = 9) or two
(n = 1) other causes for prolonged fever, mainly another
infection (seven of 10). Intraabdominal infection was the
only cause of prolonged fever in 10 of 13 patients.
Catheter-related infection was the third most common
infectious cause of prolonged fever, but in four of six
patients, it was associated with other possible causes
(intraabdominal infection, n = 2; VAP, n = 2; and
venous thrombosis, n = 1). The proportion of microor-
ganisms recovered at admission and during ICU stay
between those cultured from normally sterile sites and
those cultured from potentially contaminated sites is
displayed in Figure 2.
In noninfectious causes of fever, neurogenic fevers
were predominant, observed in 19 of 27 patients and
mainly (16 of 19) in those who had cerebral injury at
admission (Table 2). All but one case of neurogenic
fever was the only cause recognized for prolonged fever.
A thrombosis was found in four patients, but considered
the only cause of prolonged fever in only one patient
(arterial thrombosis).
Univariate analysis is presented in Tables 1 and 3. In
patients who had cerebral injury at admission, the inci-
dence of neurogenic fever did not differ between trauma
and nontrauma patients, whereas infections were more
frequently observed in trauma patients (eight of 30 ver-
sus eight of 15; P = 0.152; and 20 of 30 versus five of
15, P = 0.071, respectively). Finally, ICU and hospital
lengths of stay were increased, whereas ICU mortality
rates did not differ between the two groups (Table 4).
Age, SOFA, MacCabe, cerebral injury at admission,
severe sepsis, septic shock, ARDS, thrombosis, number of
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infections during ICU hospitalization, and duration of
mechanical ventilation were variables entered for the mul-
tivariate analysis. Independent risk factors for prolonged
fever were cerebral injury at admission (OR = 5.03; 95%
CI, 2.51 to10.06), severe sepsis (OR = 2.79; 95% CI, 1.35 to
5.79), number of infections (OR = 2.35; 95% CI, 1.43 to
3.86), and mechanical ventilation duration (OR = 1.05;
95% CI, 1.01 to 1.09). The model predicted well the risk
for prolonged fever (C-index = 0.89). Age was protective
(OR = 0.97; 95% CI, 0.96 to 0.99), with older patients
being less susceptible to developing prolonged fever.
Discussion
In this prospective study involving a large population of
critically ill patients, 17% of patients experienced pro-
longed fever. Infections were the leading cause, and
VAP, the main infection; the number of infections, the
presence of severe sepsis, and mechanical ventilation
duration were independent risk factors. Noninfectious
causes were mainly neurogenic, and cerebral injury at
admission was an independent risk factor. Finally, older
patients were less susceptible to prolonged fever. Pro-
longed fever did not affect the mortality when compared
with shorter-lasting fever.
Few studies have evaluated the incidence of prolonged
fever in critically ill patients, and none has specifically
focused on it. Notably, none described the precise etiol-
ogies and evaluated the clinical relevance. In 100 conse-
cutive patients, prolonged fever was reported in 16%; an
infective cause was recognized in all patients [1]. More
recently, in a prospective study in 493 patients, pro-
longed fever was found in 8% and was also reported to
be due to an infectious cause in 74% [3]. Finally, in a
retrospective study involving more than 20,000 patients,
prolonged fever was found in 18% [2]. The strength of
our study lies in its multicenter and prospective design,
performed during two time periods to avoid possible
temporal etiology variations, and precise description of
causes. Prolonged fever was present in 17%. Infection
was the main cause, but less frequently than previously
reported [1,3]. The first interesting and surprising find-
ing is that the most common infective site involved was
related to VAP, followed by intraabdominal sites. Never-
theless, one report indicated that times to resolution of
temperature, improvement of the PaO2/FiO2 ratio, and
improvement in leukocyte counts after antimicrobial
therapy in patients with VAP were low; the mean time
to resolution of these clinical parameters was 6 days
Table 1 Characteristics at admission
Fever
No fever
(n = 142)
≤ 5 days
(n = 278)
> 5 days
(n = 87)
P
Age, years 58 ± 18 58 ± 18 52 ± 17 0.005
Sex, male 92 (65) 187 (67) 63 (72) 0.37
McCabe score 0.05
A 72 (51) 151 (54) 63 (72)
B 51 (36) 97 (35) 17 (20)
C 19 (13) 29 (10) 7 (8)
Type of admission 0.005
Medical 34 (24) 64 (23) 15 (17)
Scheduled surgery 44 (31) 73 (26) 10 (11)
Unscheduled surgery 39 (27) 61 (22) 24 (28)
Trauma 25 (18) 80 (29) 38 (44)
Cerebral injury at admission 13 (9) 69 (25) 45 (52) < 0.001
SAPS II 34 ± 19 42 ± 19 45 ± 16 0.16
SOFA at admission 4 ± 4 6 ± 4 8 ± 4 < 0.001
At admission
Infection 32 (23) 72 (25) 21 (24) 0.74
Bacteremia 6 (4) 16 (6) 5 (6) 1.00
Site infected 0.98
Lungs 9 (6) 16 (6) 6 (7)
Intraabdominal 18 (13) 30 (11) 10 (11)
Urine 4 (3) 2 (1) 0 (0)
Catheter 0 (0) 1 (1) 0 (0)
Others 7 (5) 23 (8) 5 (6)
Comparisons are given between a fever of ≤ 5 and > 5 days. Quantitative and qualitative values are expressed as mean (SD) and n (%), respectively. SAPS II,
Simplified Acute Physiologic Score II; SOFA, Sequential Organ Failure Assessment.
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[10]. More recently, another study reported that in
patients who had VAP with and without ARDS, fever (≥
38°C) was still present in 85% and 25% after 72 hours,
respectively, despite appropriate antimicrobial therapy
[11].
In our study, the duration of mechanical ventilation
was an independent risk factor for prolonged fever and
must be interpreted in light of the high incidence of
VAP, which in turn, prolonged the need for mechanical
ventilation.
The second finding that merits emphasis is the multiple
causes of infective prolonged fever. Accordingly, our find-
ing argues for systematically searching for another cause
of prolonged fever, notably concomitant infection. Finally,
according to the high infection rate observed in patients
with prolonged fever, it not surprising that in multivariate
analysis, the number of infections was an independent risk
factor.
Severe sepsis was an independent risk factor for pro-
longed fever. Proinflammatory cytokines (endogenous
pyrogens) have a central role in the genesis of fever, and
high and prolonged levels of cytokines are expressed in
patients with severe sepsis [12,13]. The fact that severe
sepsis favors prolonged fever more than septic shock,
which produces the highest cytokines levels, is surpris-
ing. Nevertheless, in about 10% of the most severely ill
sepsis patients, the febrile response was blunted despite
an augmented cytokine response, when compared with
that in febrile patients [14].
In our study, involving a heterogeneous population of
neurologic patients in the ICU, neurogenic fever was the
second and the leading noninfectious cause for prolonged
fever. Neurogenic fever was observed in 84% of patients
who had cerebral injury, and this explains why cerebral
injury at admission was found to be an independent risk
factor. Fever in neurologic ICU patients is common, and
its incidence ranged from 22% to 47% [15,16]. Specifi-
cally, neurogenic fever was reported in 28% and 29%, and
preferentially in patients with subarachnoid hemorrhage
[15,17]. Our results are in accordance with such findings
and emphasize the value of neurologic injury as a cause
of prolonged fever, but we did not find a difference
between traumatic and nontraumatic brain injury.
Among risk factors for prolonged fever, older patients
were less susceptible to developing prolonged fever.
Thermoregulation mechanisms are well preserved in the
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Figure 2 Proportion of microorganisms recovered from
normally sterile sites (A) and those cultured from potentially
contaminated sites (B). SCN: Staphylococcus coagulase negative.
Viruses are not represented (none recovered from sterile sites and
two from potentially contaminated sites in the prolonged-fever
group).
Table 2 Detailed etiologies for prolonged fever
Causes
Infectious
Ventilator-associated pneumonia 24a
Intraabdominal infectionb 13
Catheter-related infectionc 6
Postoperative mediastinitis 5
Urinary 4
Sinusitis 3
Wounds 3
Othersd 12
Noninfectious
Neurologic 19
Thrombosis 4
Medications 1
Otherse 3
Unknown 6
Mixed causes
Infectious 10
2 9
3 1
Infectious and noninfectious 4
Values are expressed as etiologies per patient. aOne patient experienced two
episodes of ventilator-associated pneumonia; ventilator-associated pneumonia,
n = 25. bPostoperative peritonitis, n = 10; intraabdominal abscess, n = 1;
pancreatitis, n = 1; and colitis, n = 1. cCentral venous catheter, n = 5, and
arterial catheter, n = 1. dProsthetic infection, n = 2; cellulitis, n = 2; viral, n = 2;
aspiration, n = 2; empyema, n = 1; Lyell syndrome, n = 1; endocarditis, n = 1;
and pharyngeal abscess, n = 1. eHemophagocytic syndrome, n = 1; hematoma
resorption, n = 1; and arthritis, n = 1.
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elderly [18]. Nevertheless, basal temperatures are lower in
older people and in face of an infectious/inflammatory
process, both experimental and human data argue for a
lower febrile response in these patients, which may
explain our result [3,19-21].
Interestingly, mortality did not differ between patients
who had prolonged fever and those who had short-lasting
fever. Our results do not agree with those in two studies
that found a higher mortality rate in patients who had
prolonged fever [1,3]. Nevertheless, the population we
studied differed because we had a higher proportion of
patients with cerebral injury or trauma or both. Fever has
a detrimental effect on outcomes in patients with cere-
bral injury. Nevertheless, prolonged fever did not seem to
worsen the prognosis when compared with a shorter
duration of fever. Moreover, VAP represented the main
infective cause of prolonged fever in our patients, and
some studies have shown no evidence of an attributable
mortality to VAP in trauma patients [22,23].
Our study has some limitations. The definition of pro-
longed fever could be disputed. The end point of 5 days
may appear too rigid, and it could be more relevant to
consider prolonged fever as one that persists after well-
conducted antimicrobial therapy in cases of infection or
after a negative exhaustive screening search for infection.
Nevertheless, three epidemiologic studies previously
retained the threshold of 5 days for prolonged fever in
the ICU. The definitions and method we used to deter-
mine infectious and noninfectious causes of fever may
lead to over- or underdiagnoses, particularly in some cir-
cumstances in which the diagnosis is difficult and/or
nonspecific definitions exist (in VAP, in particular). Con-
versely, all the data were reviewed at the end of each hos-
pitalization, and according to the definitions proposed,
by an experienced and independent intensivist at each
center, and we believe that such an approach allows
reducing the errors that could be inherent in the design
of our study. The method of temperature measurements
we used could be criticized; the optimal site of core tem-
perature is provided by the pulmonary artery catheter,
Table 3 Clinical and biologic data during ICU hospitalization
Fever
No fever
(n = 142)
≤ 5 days
(n = 278)
> 5 days
(n = 87)
P
No. infected patients 35 (25) 133 (49) 59 (68) 0.002
No. infections/patient 0.3 ± 0.6 0.6 ± 0.7 1.6 ± 1.0 < 0.001
Site infected 0.84
Lungs 8 (6) 99 (36) 53 (61)
Intraabdominal 9 (6) 21 (8) 5 (6)
Urine 0 (0) 26 (9) 15 (17)
Catheter 0 (0) 14 (5) 11 (13)
Others 18 (13) 43 (15) 16 (18)
Bacteremia during ICU stay 2 (1) 32 (12) 31 (36) 0.004
Severe sepsis 21 (15) 62 (22) 49 (56) < 0.001
Septic shock 15 (11) 54 (19) 27 (31) 0.03
Antibiotic use 31 (22) 119 (43) 75 (86) < 0.001
Antibiotic duration, days 2 ± 4 4 ± 6 13 ± 14 < 0.001
Mechanical ventilation duration, days 2 ± 3 7 ± 9 21 ± 19 < 0.001
ARDS 6 (4) 19 (7) 20 (23) < 0.001
Acute renal failure 29 (20) 75 (27) 23 (26) 0.9
Acetaminophen use, g/day 1.0 ± 1.4 0.7 ± 0.2 1.0 ± 1.3 0.02
Extracorporeal devices use 8 (6) 39 (14) 15 (17) 0.57
Venous thrombosis 0 (0) 13 (5) 9 (10) 0.052
Maximum leukocyte count, Giga/L 15.0 ± 7.3 18.8 ± 13.2 20.3 ± 11.7 0.38
Maximum CRP level, mg/L 121 ± 99 155 ± 114 158 ± 103 0.9
Comparisons are given between a fever of ≤ 5 and > 5 days. Quantitative and qualitative values are expressed as mean (SD) and n (%), respectively. ICU,
intensive care unit; ARDS, acute respiratory distress syndrome; CRP, C-reactive protein.
Table 4 Lengths of stay and ICU mortality
Fever
No fever
(n = 142)
≤ 5 days
(n = 278)
> 5 days
(n = 87)
P
Lengths of stay, days
ICU 5 ± 4 10 ± 9 27 ± 24 < 0.001
Hospital 25 ± 30 27 ± 27 53 ± 42 < 0.001
ICU mortality 18 (13) 53 (19) 13 (15) 0.38
Comparisons are given between a fever of ≤ 5 and > 5 days. Quantitative and
qualitative values are expressed as mean (SD) and n (%), respectively. ICU,
intensive care unit.
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although this method is limited to patients requiring such
a device [5]. In critically ill patients, the temperature-
measurement site is controversial, and in fact, when com-
pared with other sites in adult patients in the ICU, the
axillary method remains accurate enough to be used in
clinical practice [24-26]. Moreover, it has been proposed
that axillary measurement with a digital thermometer has
several advantages: it is easy to use, comfortable, secure,
inexpensive, and durable [27-29].
Finally, this study was performed in surgical intensive
care units, and our results could not be extrapolated to
medical patients, who are underrepresented.
Conclusions
Prolonged fever is common in critically ill patients and
is mainly due to severe infections, particularly VAP.
Mixed causes were frequently recognized, notably infec-
tive, and such an association warrants systematic and
careful search for causes. Neurogenic fever was a fre-
quent cause of prolonged fever in patients with cerebral
injury and often observed as the only cause. Mortality
did not differ from shorter lasting fever.
Key messages
• Prolonged fever is common in critically ill patients.
• Ventilator-associated pneumonia is the leading
cause of prolonged fever.
• More than one infectious or noninfectious cause
must be carefully researched.
• In patients with cerebral injury, neurogenic fever
was a frequent cause of prolonged fever and often
observed as the only cause.
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